Edition:
United States

Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Capital Market

2.45USD
21 Sep 2017
Change (% chg)

-- (--)
Prev Close
$2.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,739
52-wk High
$3.26
52-wk Low
$2.06

Chart for

About

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including... (more)

Overall

Beta: 2.06
Market Cap(Mil.): $27.48
Shares Outstanding(Mil.): 11.40
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 78.94 16.33
EPS (TTM): -- -- --
ROI: -- 2.84 14.66
ROE: -- 4.61 13.99

BRIEF-Vical Inc Q2 loss per share $0.30

* Vical reports second quarter 2017 financial and operational results

Aug 08 2017

BRIEF-Vical presents phase 1 VL-2397 data at June ASM microbe 2017 meeting supporting advancement to phase 2

* Vical Inc - presents phase 1 vl-2397 data at June ASM microbe 2017 meeting supporting advancement to phase 2

Jun 05 2017

BRIEF-Vical Q1 loss per share $0.25

* Vical had cash and investments of $39.2 million at March 31, 2017

May 15 2017

BRIEF-Vical reports outcome of Phase 1 trial of VL-2397

* Vical highlights successful outcome of Phase 1 trial of VL-2397 novel antifungal during its research and development day Source text for Eikon: Further company coverage:

May 02 2017

BRIEF-AnGes MG plans cooperation with Vical Inc on development of genetic medication for Chronic Hepatitis B

* Says co enters into a cooperation contract with a US-based firm Vical Incorporated, on joint development of genetic medication for treatment of Chronic Hepatitis B

Apr 04 2017

Competitors

  Price Chg
Sanofi SA (SASY.PA) €84.84 +0.97
Novartis AG (NOVN.S) CHF83.10 +0.15
GlaxoSmithKline plc (GSK.L) 1,464.83 -3.16
AstraZeneca plc (AZN.L) 4,808.50 +40.00
Merck & Co., Inc. (MRK.N) $65.60 -0.19
Pfizer Inc. (PFE.N) $35.97 -0.02
Roche Holding Ltd. (ROG.S) CHF248.00 -1.00
Roche Holding Ltd. (RO.S) CHF247.90 -1.10
Genocea Biosciences Inc (GNCA.OQ) $5.29 --
Agenus Inc (AGEN.OQ) $4.10 --

Earnings vs. Estimates